All Stories

  1. Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection

    Article • Hepatology, August 2017, Wiley

    Dr Philip Rosenthal, WILLIAM BALISTRERI

  2. The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection

    Article • Hepatology, June 2017, Wiley

    Dr Philip Rosenthal, WILLIAM BALISTRERI

  3. Hepatitis C virus infection in children and adolescents

    Article • Hepatology Communications, March 2017, Wiley

    WILLIAM BALISTRERI

  4. Sclerosing Cholangitis

    Article • Cambridge University Press

    WILLIAM BALISTRERI

  5. Acute and Chronic Viral Hepatitis

    Article • Cambridge University Press

    WILLIAM BALISTRERI